Follicular Lymphoma New Drug: Mosunetuzumab for R/R Follicular Lymphoma Ulas D. Bayraktar, MD 2023-01-10
Non-Small Cell Lung Cancer New Protocol: Cemiplimab with Chemotherapy in NSCLC Ulas D. Bayraktar, MD 2023-01-10
Non-Small Cell Lung Cancer New Indication: Durvalumab with Tremelimumab in Metastatic NSCLC Ulas D. Bayraktar, MD 2023-01-10
Ovarian Cancer New Drug: Mirvetuximab Soravtansine in FRalpha Positive Ovarian Cancer Ulas D. Bayraktar, MD 2023-01-10
Melanoma New Protocol: Atezolizumab with Vemurafenib and Cobimetinib in Metastatic Melanoma Ulas D. Bayraktar, MD 2023-01-10
Chronic Lymphocytic Leukemia New Reference: Zanubrutinib for R/R CLL Ulas D. Bayraktar, MD 2023-01-10
Other diagnosis New Indication: Avelumab and Axitinib in Thymic Carcinoma Ulas D. Bayraktar, MD 2022-11-26
